TrialBlood2024
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.
Joseph Pidala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
TrialBlood2024
Joseph Pidala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.